PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Significantly reduced systolic blood pressure, diastolic blood pressure, fasting blood sugar, and hemoglobin A1c [PMID:39987124].
Significantly improved legs' heaviness and subcutaneous edema, and reduced venous pressure [PMID:11081989].
Significantly reduced salivary MMP-8 levels and serum IL-6 levels following non-surgical periodontal therapy [PMID:40362854].
Reduced smoke-induced platelet aggregation in cigarette smokers to the level of nonsmokers [PMID:10882879].
Provides photoprotection, may reduce hyperpigmentation, and improve skin barrier function and extracellular matrix homeostasis [PMID:26492562].
Studied as part of a supplement combination (with Boswellia, MSM, and curcumin) to investigate efficacy on hand pain [PMID:33617972].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38757130 (2024) — Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies. · Frontiers in nutrition
- 2.PMID: 38757126 (2024) — Review of the pharmacokinetics of French maritime pine bark extract (Pycnogenol®) in humans. · Frontiers in nutrition
- 3.PMID: 33617972 (2021) — Efficacy and safety of a supplement combination on hand pain among people with symptomatic hand osteoarthritis an internet-based, randomised clinical trial the RADIANT study. · Osteoarthritis and cartilage
- 4.PMID: 39987124 (2025) — Does supplementation with pine bark extract improve cardiometabolic risk factors? A systematic review and meta-analysis. · BMC complementary medicine and therapies
- 5.PMID: 22049273